Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study Exploring the Safety, Tolerability, and Pharmacokinetics of INCB086550 in Japanese Participants With Advanced Solid Tumors

NCT04674748 is registered in ClinicalTrials.gov with Incyte Biosciences Japan GK as lead sponsor.

NCT NCT04674748
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04674748 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study Exploring the Safety, Tolerability, and Pharmacokinetics of INCB086550 in Japanese Participants With Advanced Solid Tumors
Lead sponsor
Incyte Biosciences Japan GK
Phase
Phase 1
Overall status
Terminated
Start date
February 3, 2021
Completion date
May 13, 2022
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors